Omalizumab for the management of refractory chronic spontaneous urticaria
Chronic spontaneous urticaria (CSU) is a heterogeneous, systemic, primarily mast cell-driven disease with sudden appearance of wheals with or without angioedema with pruritus for more than 6 weeks. It affects 0.3%–0.6% of the general population. CSU is a complex immune-mediated disease due to induct...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Cyfres: | Indian Journal of Allergy Asthma and Immunology |
| Pynciau: | |
| Mynediad Ar-lein: | http://www.ijaai.in/article.asp?issn=0972-6691;year=2022;volume=36;issue=2;spage=65;epage=72;aulast=Kathuria |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|